The current institutional shareholding score of Genelux Corp is 3.00, ranking 193 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 30.96%, representing a quarter-over-quarter increase of 14.81%. The largest institutional shareholder is James Simons, holding a total of 9.65K shares, representing 0.03% of shares outstanding, with 10.29% increase in holdings.